A limited number of researches identified independent risk factors for the early recurrence of cHCC as follows: tumor size, tumor number, MiVI, MaVI, SN, lymph node metastasis, Midkine, DCP, CA19–9, and poor differentiation [4–6, 28]. This evidence concerns the gene MDK and metastatic malignant neoplasm in the lymph nodes.